Printer Friendly
The Free Library
14,581,301 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Company Profile for IMCOR Pharmaceutical Company.


Business Editors/Health/Medical Writers

--(BUSINESS WIRE)

IMCOR Pharmaceutical Co. ("IMCOR;" NASDAQ-SCM: ICPHC ICPHC International Conference on Primary Health Care ), formerly Photogen Technologies Inc., is a specialty pharmaceutical company focused on developing and marketing medical imaging pharmaceutical products. IMCOR has one FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approved product, Imagent(R) (perflexane lipid lipid

Any of a diverse class of organic compounds, found in all living things, that are greasy and insoluble in water. One of the three large classes of substances in foods and living cells, lipids contain more than twice as much energy (calories) per unit of weight as the
 microspheres), an ultrasound imaging contrast agent. The leading pipeline product is PH-50, an intravenous x-ray contrast agent for use in CT or x-ray imaging. Unlike existing x-ray agents, which leak into the interstitium within 45 seconds of entering a blood vessel blood vessel
n.
An elastic tubular channel, such as an artery, a vein, a sinus, or a capillary, through which the blood circulates.


blood vessel(s),
n the network of muscular tubes that carry blood.
, PH-50 remains in the bloodstream blood·stream
n.
The flow of blood through the circulatory system of an organism.



bloodstream

the blood flowing through the circulatory system in the living body.
 longer and allows imaging for at least 30-60 minutes. IMCOR is based in San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. .


   Company:                IMCOR Pharmaceutical Company

   Headquarters Address:   6175 Lusk Blvd.
                           San Diego, CA 92121

   Main Telephone:         (858) 410-5601

   Website:                www.imcorpharma.com

   Ticker:                 ICPHC(NASDAQ)

   Type of Organization:   Public

   Industry:               Health: Pharmaceutical

   Key Executives:         CEO: Taffy Williams
                           Sr. Vice President, Business Dev &
                            Mktg: Jack DeFranco
                           CFO: Brooks Boveroux

   Sr. VP
     Contact:              Jack DeFranco
     Phone:                (858) 410-5671
     Email:                bjd@imcorpharma.com

COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 23, 2004
Words:161
Previous Article:Company Profile for Cypress Bioscience Inc.
Next Article:Golden Tree Communications Surpasses 800 Hotels, Claiming the Number One Position for All-Wireless Hotel Internet Systems Nationwide.



Related Articles
Remodeling project underway at 475 Park Avenue South.
VALIGEN ACQUIRES BERLIN-BASED INFOGEN AND PHENOTYPE DATABASE.
IMCOR Pharmaceutical Co. Closes $2.0 Million Tranche of $10 Million Equity Financing.
IMCOR Pharmaceutical Receives Nasdaq Notice of Delisting and Plans to Restate Balance Sheet Data.
IMCOR Pharmaceutical Names Brian M. Gallagher, Ph.D. and Darlene M. Deptula-Hicks to its Board of Directors and Elects Dr. Gallagher as Chairman of...
IMCOR Pharmaceutical Co. to Present at the Roth Capital Partners New York Conference.
IMCOR Pharmaceutical Co. To Present At the Rodman & Renshaw Techvest 6th Annual Healthcare Conference.
IMCOR Pharmaceutical Co. Announces the Commencement of a Phase 2 Repeat Dosing Clinical Trial.
IMCOR Pharmaceutical Completes 2004 Annual Shareholder Meeting and Names Robert Ashley to its Board of Directors.
IMCOR Pharmaceutical Co. Receives Notice of Allowance of IMCOR's Patent Application for Imagent Entitled - ''Mixed Gas Microbubble Composition''.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles